Endo Can't Shake FTC Pay-For-Delay Suit, Judge Told
The Federal Trade Commission fought a dismissal bid Friday in an antitrust suit related to an alleged 2017 "pay-for-delay" agreement over Endo Pharmaceuticals' Opana ER painkiller, saying the drugmaker couldn't have...To view the full article, register now.
Already a subscriber? Click here to view full article